oncomedica col web


Sant Pau publishes in Cancer Immunology and Immunotherapy

The Sant Pau Medical Oncology Service, in collaboration with the Immunology and Inflammatory Diseases Research Group of the Sant Pau Research Institute-IIB, led by Dr. Silvia Vidal, has published an article in the journal Cancer Immunology and Immunotherapy. The article, “Circulating Leukocyte-platelet complex as a Predictive Biomarker for the development of immune-related Adverse events in advanced non-small cell lung cancer patients receiving anti-PD- (L) 1 blocking agents”, is the result of collaboration between the two teams over more than two years, which has led to the identification of a predictive profile of increased risk of adverse effects of immunotherapy treatment in a group of lung cancer patients receiving immunotherapy treatment.

For both teams, this represents the consolidation of a profile of multidisciplinary collaborations with other groups at the Sant Pau Research Institute in line with the strategic lines of both institutions.



Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information